Mr. Ciaran Briscoe:

I will make a brief comment. Professor Gallagher will then give another example from the sector. This will be an investment in a space where Ireland has various strengths, such as its educated workforce. Our significant international pharmaceutical presence means the potential is there for Ireland to achieve global leadership in the oncology pharmaceutical space and with that, to create jobs both north and south of the Border, which will be of high quality and sustainable into the future. I emphasise again the economic benefits that could be involved in AICRI creating the kind of ecosystem within which SMEs and existing foreign direct investment, FDI, can continue to progress.